Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Jaypirca is making waves in the fight against B-cell malignancies
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
Call it a major milestone in bladder cancer therapy that aims to provide a lifeline for patients who previously had limited options
Winlevi is authorized in EU for the treatment of acne vulgaris
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Subscribe To Our Newsletter & Stay Updated
